Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03060278 · ClinicalTrials.gov registry record · Phase 4
Smartphone-delivered Automated Video-assisted Smoking Treatment for Patrons of a Food Resource Center
A Phase 4 study of Smoking Cessation, sponsored by University of Oklahoma.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03060278: Completed Phase 4 study of Smoking Cessation, sponsored by University of Oklahoma.
NCT03060278 is a Phase 4 study of Smoking Cessation that has completed, run by University of Oklahoma. The registered enrollment target is 20 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03060278, a Phase 4 study of Smoking Cessation, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed pilot study seeks to address the smoking cessation treatment needs of underserved smokers with limited resources by evaluating the feasibility and preliminary efficacy of a smartphone delivered automated video-assisted smoking treatment (AVAST). AVAST will enable smoking cessation treatment content to be presented with voice/audio, images, videos, and text in an interactive, structured format anytime and anywhere. Participants will be recruited from the Urban Mission, a non-profit food and resource center that serves approximately 20,000 people each year in the Oklahoma City metro area.
Primary Outcome
Biochemically verifying smoking status on all participants by collecting an expired carbon monoxide breath sample.
Conditions Studied
Interventions
- BEHAVIORAL Counseling
- BEHAVIORAL Self-help materials
- DRUG nicotine patch
- OTHER Smartphone-delivered automated treatment
Study Locations (1)
Oklahoma
- Oklahoma Tobacco Research Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2017-12-31 |
| Phase | Phase 4 |
What the finished NCT03060278 record still lists
NCT03060278 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Counseling is the first listed.
NCT03060278 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT03060278 about?
NCT03060278 is a clinical study titled "Smartphone-delivered Automated Video-assisted Smoking Treatment for Patrons of a Food Resource Center". The proposed pilot study seeks to address the smoking cessation treatment needs of underserved smokers with limited resources by evaluating the feasibility and preliminary efficacy of a smartphone delivered automated video-assisted smoking treatment (AVAST). AVAST will enable smoking cessation treat...
What is the current status of trial NCT03060278?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2017-05-15. Estimated completion is 2017-12-31.
What conditions does trial NCT03060278 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT03060278?
The interventions under investigation include: Counseling (BEHAVIORAL), Self-help materials (BEHAVIORAL), nicotine patch (DRUG), Smartphone-delivered automated treatment (OTHER).
Who is sponsoring clinical trial NCT03060278?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03060278 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03060278's enrollment target sits among peer trials
20 173rd of 188 higher than 10 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI